The Unique Physicochemical Properties of 2.5% Injectable Polyacrylamide Hydrogel (iPAAG) in Joint Lameness Treatment
Introduction The management of osteoarthritis (OA) in equine patients has seen significant advancements with the introduction of 2.5% injectable Polyacrylamide Hydrogel (iPAAG), commercially known as Arthramid®. This short article explores…
The concurrent use of 2.5% polyacrylamide hydrogel and betamethasone esters for intra-articular injection is well tolerated in 10 healthy horses
The Journal of the American Veterinary Medical Association (JAVMA) has recently published a study looking at the safety and tolerability of concurrent use of Arthramid and betamethasone. This research was…
Webinar: Palmar Foot Pain | Advances and Updates in Equine Podiatry
ArthramidVet hosted this discussion with Dr Andrew Watts and Dr Tracy Turner, experts in equine foot health. Our Panelists Dr Andrew Watts (AU): Graduating from University of Queensland in…
Dr Lisa Fortier Seminar | Intra-Articular Approaches to Osteoarthritis
ArthramidVet® and the NZVA offered an exclusive opportunity to hear from the esteemed Dr Lisa Fortier who, alongside Dr Jason Lowe, discussed Intra-Articular Approaches to Osteoarthritis, a general topic…
Histologic and cytologic changes in normal equine joints after injection with 2.5% iPAAG hydrogel reveal low-level macrophage-driven foreign body response
The prestigious American Veterinary Medicine Association has published another 2.5% iPAAG (ArthramidVet®) study conducted by IMS Vet Directors Dr Jason Lowe and Dr Leigh de Clifford, in keeping with our…
What is a ‘joint-flare’ and can it happen with 2.5% iPAAG (ArthramidVet®)?
Intraarticular injections in horses are beneficial for managing various musculoskeletal conditions, but they do come with associated risks and should be performed by a suitably qualified and experienced veterinarian. Furthermore,…
New and Upcoming Advances in Equine Orthopedics
Updates on 2.5% iPAAG (Polyacrylamide Hydrogel) In our latest webinar, a number of expert practitioners discussed the latest findings of the use of 2.5% iPAAG (ArthramidVet) and upcoming advances. EquiManagement…
Recommendations and Safety of repeat dosing with 2.5% iPAAG ArthramidVet®
Introduction ArthramidVet® is a novel treatment and represents a paradigm shift in how veterinarians and owners think about treating lameness in horses. ArthramidVet® can be used in any joint that…
Understanding Equine Arthritis: An Owner Guide to Treatment and Ethical Considerations
Navigating the Treatment Pyramid, Orthobiologics, and the Nutraceutical Conundrum Introduction Equine arthritis is a prevalent and concerning health issue that affects horses worldwide. It not only poses welfare challenges…
Dr Florent David at Vet Fest Australia
View On Demand. VetFest Marketplace – A dedicated Industry Week for the Veterinary Profession View this 40 minute video presentation as Dr Florent David (DVM, MS, Dipl. ACVS & ECVS,…
Arthrosamid 2.5% iPAAG – The Human Equivalent
Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Arthrosamid® is a new type of treatment for knee osteoarthritis that…
Use of ArthramidVet in Canine Intra-articular injections
Nupsala Learning Resources in the UK recently published a webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique…
